{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:19:33Z","timestamp":1761844773474,"version":"3.41.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000148","name":"Canadian Anesthesiologists' Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000148","id-type":"DOI","asserted-by":"publisher"}]},{"name":"College of Pharmacy, Dalhousie University (CA)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12630-017-0933-x","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T17:01:57Z","timestamp":1500051717000},"page":"1009-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid","Les effets d\u2019une r\u00e9action inflammatoire induite par chirurgie sur la distribution de morphine et de ses m\u00e9tabolites dans le liquide c\u00e9phalorachidien\u00a0: une \u00e9tude observationnelle"],"prefix":"10.1007","volume":"64","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry B.","family":"Goralski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekha","family":"Sleno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa C.","family":"Julien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7666-889X","authenticated-orcid":false,"given":"Richard I.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"933_CR1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1517\/17425255.2013.799137","volume":"9","author":"DJ Roberts","year":"2013","unstructured":"Roberts DJ, Hall RI. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults. Expert Opin Drug Metab Toxicol 2013; 9: 1067-84.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"933_CR2","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1097\/CCM.0b013e3181b755d5","volume":"37","author":"DJ Roberts","year":"2009","unstructured":"Roberts DJ, Goralski KB, Renton KW, et al. Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain. Crit Care Med 2009; 37: 2767-74.","journal-title":"Crit Care Med"},{"key":"933_CR3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/CCM.0b013e318275d014","volume":"41","author":"Y Skrobik","year":"2013","unstructured":"Skrobik Y, Leger C, Cossette M, Michaud V, Turgeon J. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 2013; 41: 999-1008.","journal-title":"Crit Care Med"},{"key":"933_CR4","doi-asserted-by":"crossref","unstructured":"McNeil JO, Goralski KB. Drug-cytokine interactions. In: Piscitelli SC, Rodvold KA, Pai MP (Eds). Drug Interactions in Infectious Diseases, 3rd Edition. New York, Springer Science and Business Media; 2011.","DOI":"10.1007\/978-1-61779-213-7_6"},{"key":"933_CR5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"AH Schinkel","year":"1995","unstructured":"Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. Absence of the mdr1a P-gGlycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995; 96: 1698-705.","journal-title":"J Clin Invest"},{"key":"933_CR6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","volume":"96","author":"C Wandel","year":"2002","unstructured":"Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 2002; 96: 913-20.","journal-title":"Anesthesiology"},{"key":"933_CR7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/85115","volume":"4","author":"M King","year":"2001","unstructured":"King M, Su W, Chang A, Zuckerman A, Pasternak GW. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci 2001; 4: 268-74.","journal-title":"Nat Neurosci"},{"key":"933_CR8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","volume":"92","author":"SJ Thompson","year":"2000","unstructured":"Thompson SJ, Koszdin K, Bernards CM. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 2000; 92: 1392-9.","journal-title":"Anesthesiology"},{"key":"933_CR9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(24)11822-3","volume":"27","author":"SP Letrent","year":"1999","unstructured":"Letrent SP, Pollack GM, Brouwer KR, Brouwer KL. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat. Drug Metab Dispos 1999; 27: 827-34.","journal-title":"Drug Metab Dispos"},{"key":"933_CR10","first-page":"592","volume":"54","author":"I Meineke","year":"2002","unstructured":"Meineke I, Freudenthaler S, Hofmann U, et al. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol 2002; 54: 592-603.","journal-title":"Br J Clin Pharmacol"},{"key":"933_CR11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/ALN.0b013e3182a05bd3","volume":"119","author":"K Meissner","year":"2013","unstructured":"Meissner K, Avram MJ, Yermolenka V, Francis AM, Blood J, Kharasch ED. Cyclosporine-inhibitable blood-brain barrier drug transport influences clinical morphine pharmacodynamics. Anesthesiology 2013; 119: 941-53.","journal-title":"Anesthesiology"},{"key":"933_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/tpj.2014.56","volume":"15","author":"S Sadhasivam","year":"2015","unstructured":"Sadhasivam S, Chidambaran V, Zhang X, et al. Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. Pharmacogenomics J 2015; 15: 119-26.","journal-title":"Pharmacogenomics J"},{"key":"933_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/03602539608994011","volume":"28","author":"RW Milne","year":"1996","unstructured":"Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev 1996; 28: 345-472.","journal-title":"Drug Metab Rev"},{"key":"933_CR14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/bja\/aeu186","volume":"113","author":"R Klimas","year":"2014","unstructured":"Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth 2014; 113: 935-44.","journal-title":"Br J Anaesth"},{"key":"933_CR15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","volume":"27","author":"MT Smith","year":"2000","unstructured":"Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000; 27: 524-8.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"933_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","volume":"125","author":"DS Miller","year":"2015","unstructured":"Miller DS. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly. Adv Cancer Res 2015; 125: 43-70.","journal-title":"Adv Cancer Res"},{"key":"933_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/mol.107.035592","volume":"72","author":"K Wetering van de","year":"2007","unstructured":"van de Wetering K, Zelcer N, Kuil A, et al. Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol Pharmacol 2007; 72: 387-94.","journal-title":"Mol Pharmacol"},{"key":"933_CR18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/17425255.4.10.1245","volume":"4","author":"DJ Roberts","year":"2008","unstructured":"Roberts DJ, Goralski KB. A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin Drug Metab Toxicol 2008; 4: 1245-64.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"933_CR19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.106.029512","volume":"71","author":"B Bauer","year":"2007","unstructured":"Bauer B, Hartz AM, Miller DS. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 2007; 71: 667-75.","journal-title":"Mol Pharmacol"},{"key":"933_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10571-009-9431-1","volume":"30","author":"B Poller","year":"2010","unstructured":"Poller B, Drewe J, Krahenbuhl S, Huwyler J, Gutmann H. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell Mol Neurobiol 2010; 30: 63-70.","journal-title":"Cell Mol Neurobiol"},{"key":"933_CR21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/mol.106.025973","volume":"70","author":"PT Ronaldson","year":"2006","unstructured":"Ronaldson PT, Bendayan R. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharmacol 2006; 70: 1087-98.","journal-title":"Mol Pharmacol"},{"key":"933_CR22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1159\/000110445","volume":"20","author":"C Yu","year":"2007","unstructured":"Yu C, Kastin AJ, Tu H, Waters S, Pan W. TNF activates P-glycoprotein in cerebral microvascular endothelial cells. Cell Physiol Biochem 2007; 20: 853-8.","journal-title":"Cell Physiol Biochem"},{"key":"933_CR23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/mol.109.059410","volume":"77","author":"PT Ronaldson","year":"2010","unstructured":"Ronaldson PT, Ashraf T, Bendayan R. Regulation of multidrug resistance protein 1 by tumor necrosis factor alpha in cultured glial cells: involvement of nuclear factor-kappaB and c-Jun N-terminal kinase signaling pathways. Mol Pharmacol 2010; 77: 644-59.","journal-title":"Mol Pharmacol"},{"key":"933_CR24","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1471-4159.2007.04644.x","volume":"102","author":"MJ Seelbach","year":"2007","unstructured":"Seelbach MJ, Brooks TA, Egleton RD, Davis TP. Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J Neurochem 2007; 102: 1677-90.","journal-title":"J Neurochem"},{"key":"933_CR25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/dmd.108.024745","volume":"37","author":"S Syvanen","year":"2009","unstructured":"Syvanen S, Lindhe O, Palner M, et al. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos 2009; 37: 635-43.","journal-title":"Drug Metab Dispos"},{"key":"933_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jneumeth.2011.05.012","volume":"199","author":"K Hatherell","year":"2011","unstructured":"Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 2011; 199: 223-9.","journal-title":"J Neurosci Methods"},{"key":"933_CR27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","volume":"18","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18: 800-4.","journal-title":"Epidemiology"},{"key":"933_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.athoracsur.2012.04.044","volume":"94","author":"B Reinsfelt","year":"2012","unstructured":"Reinsfelt B, Ricksten SE, Zetterberg H, Blennow K, Freden-Lindqvist J, Westerlind A. Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann Thorac Surg 2012; 94: 549-55.","journal-title":"Ann Thorac Surg"},{"key":"933_CR29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/j.jvca.2012.09.013","volume":"27","author":"R Hall","year":"2013","unstructured":"Hall R. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27: 983-1033.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"933_CR30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bmj.308.6933.896","volume":"308","author":"JM Bland","year":"1994","unstructured":"Bland JM, Altman DG. Correlation, regression, and repeated data. BMJ 1994; 308: 896.","journal-title":"BMJ"},{"key":"933_CR31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hlc.2014.04.131","volume":"23","author":"K Bartels","year":"2014","unstructured":"Bartels K, Ma Q, Venkatraman TN, et al. Effects of deep hypothermic circulatory arrest on the blood brain barrier in a cardiopulmonary bypass model\u2013a pilot study. Heart Lung Circ 2014; 23: 981-4.","journal-title":"Heart Lung Circ"},{"key":"933_CR32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/00000539-199710000-00011","volume":"85","author":"RI Hall","year":"1997","unstructured":"Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997; 85: 766-82.","journal-title":"Anesth Analg"},{"key":"933_CR33","first-page":"2402","volume":"7","author":"DN Moris","year":"2014","unstructured":"Moris DN, Kontos MI, Mantonakis EI, et al. Concept of the aortic aneurysm repair-related surgical stress: a review of the literature. Int J Clin Exp Med 2014; 7: 2402-12.","journal-title":"Int J Clin Exp Med"},{"key":"933_CR34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1510\/icvts.2007.157339","volume":"6","author":"E Akowuah","year":"2007","unstructured":"Akowuah E, Wilde P, Angelini G, Bryan AJ. Systemic inflammatory response after endoluminal stenting of the descending thoracic aorta. Interact Cardiovasc Thorac Surg 2007; 6: 741-3.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"933_CR35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.","journal-title":"Nat Rev Neurosci"},{"key":"933_CR36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fncel.2015.00028","volume":"9","author":"R Sankowski","year":"2015","unstructured":"Sankowski R, Mader S, Valdes-Ferrer SI. Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci 2015; 9: 28.","journal-title":"Front Cell Neurosci"},{"key":"933_CR37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/J354v16n04_02","volume":"16","author":"RA Lugo","year":"2002","unstructured":"Lugo RA, Kern SE. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother 2002; 16: 5-18.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"933_CR38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/jpet.113.212258","volume":"349","author":"N Chau","year":"2014","unstructured":"Chau N, Elliot DJ, Lewis BC, et al. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. J Pharmacol Exp Ther 2014; 349: 126-37.","journal-title":"J Pharmacol Exp Ther"},{"key":"933_CR39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.30.2.129","volume":"30","author":"M Congiu","year":"2002","unstructured":"Congiu M, Mashford ML, Slavin JL, Desmond PV. UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 2002; 30: 129-34.","journal-title":"Drug Metab Dispos"},{"key":"933_CR40","unstructured":"Sandouk P, Serrie A, Scherrmann JM, Langlade A, Bourre JM. Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine. Eur J Drug Metab Pharmacokinet 1991; Spec No 3: 166-71."},{"key":"933_CR41","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.112.196543","volume":"343","author":"CJ Gibson","year":"2012","unstructured":"Gibson CJ, Hossain MM, Richardson JR, Aleksunes LM. Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia. J Pharmacol Exp Ther 2012; 343: 650-60.","journal-title":"J Pharmacol Exp Ther"},{"key":"933_CR42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/mcbr.2001.0288","volume":"4","author":"M Sukhai","year":"2000","unstructured":"Sukhai M, Yong A, Kalitsky J, Piquette-Miller M. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes. Mol Cell Biol Res Commun 2000; 4: 248-56.","journal-title":"Mol Cell Biol Res Commun"},{"key":"933_CR43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0022-202X.2004.23499.x","volume":"124","author":"A Dreuw","year":"2005","unstructured":"Dreuw A, Hermanns HM, Heise R, et al. Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J Invest Dermatol 2005; 124: 28-37.","journal-title":"J Invest Dermatol"},{"key":"933_CR44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1139\/y01-071","volume":"79","author":"G Lee","year":"2001","unstructured":"Lee G, Piquette-Miller M. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 2001; 79: 876-84.","journal-title":"Can J Physiol Pharmacol"},{"key":"933_CR45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2005.06.006","volume":"116","author":"C Skarke","year":"2005","unstructured":"Skarke C, Geisslinger G, Lotsch J. Is morphine-3-glucuronide of therapeutic relevance? Pain 2005; 116: 177-80.","journal-title":"Pain"},{"key":"933_CR46","doi-asserted-by":"crossref","first-page":"8743187","DOI":"10.1155\/2016\/8743187","volume":"2016","author":"M Hubner","year":"2016","unstructured":"Hubner M, Mantziari S, Demartines N, Pralong F, Coti-Bertrand P, Schafer M. Postoperative albumin drop is a marker for surgical stress and a predictor for clinical outcome: a pilot study. Gastroenterol Res Pract 2016; 2016: 8743187.","journal-title":"Gastroenterol Res Pract"},{"key":"933_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cpt197517131","volume":"17","author":"GD Olsen","year":"1975","unstructured":"Olsen GD. Morphine binding to human plasma proteins. Clin Pharmacol Ther 1975; 17: 31-5.","journal-title":"Clin Pharmacol Ther"},{"key":"933_CR48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","volume":"83","author":"D Campa","year":"2008","unstructured":"Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 2008; 83: 559-66.","journal-title":"Clin Pharmacol Ther"},{"key":"933_CR49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini C, Paus E, Buclin T, Kim RB. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 2004; 75: 13-33.","journal-title":"Clin Pharmacol Ther"},{"key":"933_CR50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","volume":"10","author":"DJ Begley","year":"2004","unstructured":"Begley DJ. ABC transporters and the blood-brain barrier. Curr Pharm Des 2004; 10: 1295-312.","journal-title":"Curr Pharm Des"},{"key":"933_CR51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1389200043489126","volume":"5","author":"CL Graff","year":"2004","unstructured":"Graff CL, Pollack GM. Drug transport at the blood-brain barrier and the choroid plexus. Curr Drug Metab 2004; 5: 95-108.","journal-title":"Curr Drug Metab"},{"key":"933_CR52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejcts.2005.07.007","volume":"28","author":"A Franke","year":"2005","unstructured":"Franke A, Lante W, Fackeldey V, et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005; 28: 569-75.","journal-title":"Eur J Cardiothorac Surg"},{"key":"933_CR53","doi-asserted-by":"crossref","unstructured":"Franke A, Lante W, Fackeldey V, et al. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Ann Thorac Surg 2002; 74: 363-70; discussion 370-1.","DOI":"10.1016\/S0003-4975(02)03658-5"},{"key":"933_CR54","doi-asserted-by":"crossref","unstructured":"Teoh KH, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 1995; 92: II347-53.","DOI":"10.1161\/01.CIR.92.9.347"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-017-0933-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0933-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0933-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T21:47:26Z","timestamp":1750628846000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-017-0933-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1007\/s12630-017-0933-x","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"type":"print","value":"0832-610X"},{"type":"electronic","value":"1496-8975"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}